How Do These Pharmas Really Boost Their Returns?

above 30% in the two years prior. Still, asset turnover looks low relative to competitors. While Abbott and Pfizer have similar margins, Abbott doubles Pfizer's ROE, largely because of much higher asset turnover despite lower leverage. Glaxo also notches...